ANTIBACTERIAL ACTIVITY STUDY (IN SILICO & IN VITRO) OF SOME COUMARIN MOLECULES AS LIGANDS AGAINST STREPTOCOCCUS PYOGENES BACTERIA

Abdalkader Saeed  Latif; Ihab Q.  Ali; Ammar Basim  Al-Asadi; Shahla Hussien  Huno

doi:10.21272/eumj.2025;13(3):806-812

Abdalkader Saeed Latif Polymers Research Unit, College Of Science, Mustansiriyah University, Baghdad, Iraq https://orcid.org/0000-0003-1901-9425
Ihab Q. Ali Ibn Sina University of medical and Pharmaceutical Sciences, Iraq, Baghdad https://orcid.org/0000-0002-5788-1393
Ammar Basim Al-Asadi Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad https://orcid.org/0000-0002-2444-2714
Shahla Hussien Huno Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad https://orcid.org/0000-0002-5070-3682

DOI: https://doi.org/10.21272/eumj.2025;13(3):806-812

Keywords: in silico study, in vitro study, coumarin ligands, Streptococcus pyogenes

Abstract

Background: Coumarin derivatives have emerged as a potential antimicrobial agent due to their broad spectrum of biological activities.

Objective: Antibacterial activity against Streptococcus pyogenes is analyzed by the study of binding potentials and efficiencies of five coumarin ligands (L1, L2, L3, L4, L5) were compared to the conventional antibiotic. Clinical samples were collected from Iraqi patients attending the teaching hospital from June to October of 2023. Streptococcus pyogenes was isolated and characterized; 23 of these were confirmed by the VITEK 2 system. The susceptibility testing of the different isolated bacteria to a range of antibiotics, including Sulfamethoxazole, was carried out using the disc diffusion.

Methods: The resistant ones were further tested with the coumarin molecules ligands (L1, L2, L3, L4, L5) using the agar well diffusion method.

Results: Ligand number L3 showed the highest binding affinity for the Streptococcus pyogenes enzyme glycosyltransferase with a binding energy of (-38.7 Kcal/mol), representing the strong inhibiting potential of the drug. Resistance in clinical isolates was 32% to Sulfamethoxazole and showed variable susceptibility patterns to other antibiotics tested. Among these resistant strains, L3 has shown the strongest antibacterial activity, its MIC equal to (256 µg/ml), exceeding Sulfamethoxazole, while on the other hand, ligands L1, L4, and L5 gave moderate antibacterial activities, while L2, on the other hand, was found to be the least active because it gave an MIC value of (1024 µg/ml). In this study, ligand L3 was identified as a strong antibacterial agent against Streptococcus pyogenes, particularly in strains which are resistant to Sulfamethoxazole.

Conclusion: L3 molecule has strong binding affinity and effectiveness to bind directly with the side chain of an amino acid, which conforms to the active side of the glycosyltransferase enzyme in target bacteria. It blocked it and led to malfunctioning of the target enzyme. Therefore, it is a promising alternative to the traditional antibiotics. Further research on coumarin derivatives may help in getting new antibiotic-resistant illness treatments.

Downloads

Download data is not yet available.

References

Latif AS, Magtooph MG, Alubadi AEM. In silico and In vitro evaluation of some synthesized quinoline derivatives into MexB protein of Pseudomonas aeruginosa. International Journal of Drug DeliveryTechnology, 2020;10(2),195-199. https://ijddt.com/volume10issue2

Chandra SM, Gupta RA. Synthesis and biological evaluation of coumarin derivatives as antimicrobial agents. European Journal of MedicinalChemistry. 2023;239,114496. https://doi.org/10.1016/j.ejmech.2023.114496

Davis KE, Patel RS. Structure-activity relationships and antibacterial mechanisms of coumarin derivatives. Bioorganic & Medicinal Chemistry Letters. 2023;33,129873. https://doi.org/10.1016/j.bmcl.2023.129873

Davis M, Thompson J. In vitro assays for antibacterial activity. Methods in Microbiology. 2024;34, 101-115. https://pmc.ncbi.nlm.nih.gov/articles/PMC5762448/.

Johnson R, Walker C. Streptococcus pyogenes and antibiotic resistance. Journal of Bacteriology. 2024; 206(3), 89-102. https://pmc.ncbi.nlm.nih.gov/articles/PMC11314938/

Kim JH, Park SH. Exploring the antibacterial potential of coumarin compounds through molecular docking and dynamic simulation studies. Journal of Molecular Graphics and Modelling. 2024;121, 108086. https://doi.org/10.1016/j.jmgm.2023.108086

Patel A, Green D. Molecular docking studies on antibacterial agents. Bioinformatics and Biology Insights. 2024; 18, 45-59. https://www.sciencedirect.com/science/article/pii/S2211715624003588.

Venugopala KN, Rashmi V, Odhav B. Review on natural coumarin lead compounds for their pharmacological activity. BioMed Research International. 2018; 1-14. https://doi.org/10.1155/2013/963248.

Wang H, Lu X, Yao H, Feng J, Liu R. Research progress on application of coumarin and its derivatives. Chemical Industry Times, 2019; 23(8), 40-43. https://pmc.ncbi.nlm.nih.gov/articles/PMC8788346/.

Wang XY, Zhao QF. Antibacterial evaluation and mechanism studies of synthetic coumarin derivatives against pathogenic bacteria. Chemico-Biological Interactions, 2023;369,110045. https://doi.org/10.1016/j.cbi.2023.110045.

Latif AS, Al-Jumaily EF. Evaluation study of coumarin molecules against glycosyltransferase enzyme of Streptococcus pneumoniae. International Journal of Pharmaceutical Research, 2020;12,808-813. http://www.ijpronline.com/ViewSpecialArticleDetail.aspx?ID=207.

Latif AS, Fadel ZA. Evaluation study of the effectiveness for some antibacterial agent against DNA gyrase enzyme of Staphylococcus aureus. European Chemical Bulletin, 2022;11(7),29-32. https://doi.org/10.31838/ecb/2022.11.07.005.

Bubols GB, Vianna, DR, Medina A, Von G, Lamuela RM, Eifler VL, et al. The antioxidant activity of coumarins and flavonoids. Mini-Reviews in Medicinal Chemistry, 2017;13(3),318-334. https://doi.org/10.2174/1389557511313030002.

Delfani, S, Khorramabadi RM, Abbaszadeh S, Naghdi N, Shahsavari S. Phytotherapy for Streptococcus pyogenes. Journal of Pharmaceutical Sciences and Research, 2017; 9(5), 513. https://www.jpsr.pharmainfo.in/Documents/Volumes/vol9Issue05/jpsr09051702.pdf.

Lee HK, Choi MJ. Coumarins as potent antibacterial agents: An insight into their mechanism of action. Journal of Molecular Structure, 2023;1282, 135012. https://doi.org/10.1016/j.molstruc.2023.135012

Lovering AL, De Castro LH, Lim D, Strynadka N. Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis. Science, 2017; 315, 1402. https://pubmed.ncbi.nlm.nih.gov/17347437/.

Williams PR, Smith TL. In vitro antibacterial activity of newly synthesized coumarin derivatives against Streptococcus pyogenes. Journal of Antimicrobial Chemotherapy, 2023;78(3),456-463. https://doi.org/10.1093/jac/dkaa456.

Yuan Y, Barrett D, Zhang Y, Kahne D, Sliz P, Walker S. Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis. Proceedings of the National Academy of Sciences of the United States of America, 2015;104, 5348. https://doi.org/10.1073/pnas.0701160104.

Rohman N, Ardiansah B, Wukirsari T, Judeh Z. Recent trends in synthesis and bioactivity of coumarin, coumarin-chalcone, and coumarin-triazole molecular bybrid. Molecules 2024, 29(5), 1026; https://doi.org/10.3390/molecules29051026

Martinez AF, Garcia HM. Evaluation of coumarins as potential antibacterial agents: A comprehensive review. Pharmacological Research, 2023;192,106415. https://doi.org/10.1016/j.phrs.2023.106415.

Matos MJ, Vazquez S, Santana L, Uriarte E, Fuentes C, Santos Y. Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents. Molecules, 2013;18(2), 1394-1404. https://doi.org/10.3390/molecules1802139.

Moréra L, Larivière J, Kurzeck U, Aschke S, Paul SF, Joë J, Wolfgang R. High resolution crystal structures of T4 phage β-glucosyltransferase: Induced fit and effect of substrate and metal binding. Journal of Molecular Biology, 2013;311, 569-577. https://pubmed.ncbi.nlm.nih.gov/11493010/.

Nguyen TH, Le VT. In silico and in vitro analysis of coumarin analogs as novel antibacterial agents against gram-positive bacteria. Journal of Chemical Information and Modeling, 2023; 63(1), 678-689. https://doi.org/10.1021/acs.jcim.2c01358.